Danaher (DHR)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Danaher | DHR | Healthcare | Diagnostics & Research | 85 | 4.3% |
Current Price ( 3/18 4:00PM EDT) | $251.47 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 23,890.0 | |||
Sales Growth Forecast | 5.3% | |||
Net Profit Margin | 25.5% | |||
Projected Shares Outstanding | 730.22 | |||
EPS - Five year Forecast | $10.82 | |||
Average P/E Ratio | 28.0 | |||
Projected Average Price | $302.87 | |||
Price Appreciation (Annualized) | 3.8% | |||
Annual Dividend Yield | 0.5% | |||
Projected Annual Return | 4.3% | |||
Quality | ||||
Financial Strength | 95 | 23.7 | ||
EPS Stability | 71 | 17.8 | ||
Industry Sales Growth Rate | 9.5% | 7.0 | ||
Industry Net Profit Margin | 17.5% | 18.2 | ||
Calculated Quality Rating | 66.7 | |||
Fool CAPS | ||||
Total Players
599
Outperforms
25
Underperforms
All-Stars (111)
107
Outperforms (96%)
4
Underperforms
|
||||
Fundamental Data Updated: 01/05/2024 |